Vireo Growth (VREOF) Treasury Shares (2022 - 2026)
Vireo Growth's (VREOF) quarterly Treasury Shares came in at $59.6 million in Q1 2026, down 16.29% year-on-year from $71.2 million in Q1 2025, and up 425.84% quarter-over-quarter from $11.3 million in Q4 2025.
Vireo Growth (VREOF) Treasury Shares (2022 - 2026) Analysis & Trends
Vireo Growth has disclosed Treasury Shares across 5 years of filings, most recently posting $59.6 million for Q1 2026.
- Treasury Shares for Q1 2026 came in at $59.6 million, down 16.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.6 million (down 16.29% YoY), and the FY2025 annual result was $11.3 million, changed 0.0% from the prior year.
- Treasury Shares came in at $59.6 million for Q1 2026 at Vireo Growth, up from $11.3 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $73.2 million in Q3 2025 to a low of $1.1 million in Q1 2022.
- The 5-year median for Treasury Shares is $3.1 million (2023), against an average of $19.2 million.
- Across the five-year window, Treasury Shares retreated 21.07% in 2023 and jumped 2782.87% in 2025, its largest moves.
- Vireo Growth's Treasury Shares stood at $3.2 million in 2022, then fell by 21.07% to $2.5 million in 2023, then surged by 345.44% to $11.3 million in 2024, then changed by 0.0% to $11.3 million in 2025, then jumped by 425.84% to $59.6 million in 2026.
- The last three Treasury Shares figures came in at $59.6 million (Q1 2026), $11.3 million (Q4 2025), and $73.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 107.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.80 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.42 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 17.13 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 19.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 7.24 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 59.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.57 Mn |
| Mar 31, 2026 | 59.57 Mn |
| Dec 31, 2025 | 11.33 Mn |
| Dec 31, 2025 | 11.33 Mn |
| Sep 30, 2025 | 73.17 Mn |
| Sep 30, 2025 | 73.17 Mn |
| Jun 30, 2025 | 72.10 Mn |
| Jun 30, 2025 | 72.10 Mn |
| Mar 31, 2025 | 71.16 Mn |
| Mar 31, 2025 | 71.16 Mn |
| Dec 31, 2024 | 11.33 Mn |
| Dec 31, 2024 | 11.33 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Dec 31, 2023 | 2.54 Mn |